Predictors of QT Interval Prolongation in Critically-ill Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine
View ORCID ProfileFrederico Scuotto, Rogério Marra, Lilian Leite de Almeida, Mariana Santa Rita Soares, Gabriela Kurita Silva, Luiz Carlos Paul, Guilherme Drummond Fenelon Costa, Cláudio Cirenza
doi: https://doi.org/10.1101/2020.11.26.20239418
Frederico Scuotto
All authors are affiliated to the Hospital Samaritano Higienópolis, United Health Group, São Paulo, Brazil
MD, CEPS-ACRogério Marra
All authors are affiliated to the Hospital Samaritano Higienópolis, United Health Group, São Paulo, Brazil
MDLilian Leite de Almeida
All authors are affiliated to the Hospital Samaritano Higienópolis, United Health Group, São Paulo, Brazil
BSc PharmMariana Santa Rita Soares
All authors are affiliated to the Hospital Samaritano Higienópolis, United Health Group, São Paulo, Brazil
BSc PharmGabriela Kurita Silva
All authors are affiliated to the Hospital Samaritano Higienópolis, United Health Group, São Paulo, Brazil
BSc PharmLuiz Carlos Paul
All authors are affiliated to the Hospital Samaritano Higienópolis, United Health Group, São Paulo, Brazil
MDGuilherme Drummond Fenelon Costa
All authors are affiliated to the Hospital Samaritano Higienópolis, United Health Group, São Paulo, Brazil
MD, PhDCláudio Cirenza
All authors are affiliated to the Hospital Samaritano Higienópolis, United Health Group, São Paulo, Brazil
MD, PhD
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.
Posted November 30, 2020.
Predictors of QT Interval Prolongation in Critically-ill Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine
Frederico Scuotto, Rogério Marra, Lilian Leite de Almeida, Mariana Santa Rita Soares, Gabriela Kurita Silva, Luiz Carlos Paul, Guilherme Drummond Fenelon Costa, Cláudio Cirenza
medRxiv 2020.11.26.20239418; doi: https://doi.org/10.1101/2020.11.26.20239418
Predictors of QT Interval Prolongation in Critically-ill Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine
Frederico Scuotto, Rogério Marra, Lilian Leite de Almeida, Mariana Santa Rita Soares, Gabriela Kurita Silva, Luiz Carlos Paul, Guilherme Drummond Fenelon Costa, Cláudio Cirenza
medRxiv 2020.11.26.20239418; doi: https://doi.org/10.1101/2020.11.26.20239418
Subject Area
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3112)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13049)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4871)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3072)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (963)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4641)
- Nursing (247)
- Nutrition (689)
- Oncology (2395)
- Ophthalmology (679)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (307)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7206)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)